Omega Healthcare Investors Terminates Material Agreement
Ticker: OHI · Form: 8-K · Filed: Oct 15, 2025 · CIK: 888491
| Field | Detail |
|---|---|
| Company | Omega Healthcare Investors Inc (OHI) |
| Form Type | 8-K |
| Filed Date | Oct 15, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10, $600 million, $607,875,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, material-event
Related Tickers: OHI
TL;DR
OHI terminated a big deal, details TBD.
AI Summary
Omega Healthcare Investors, Inc. (OHI) filed an 8-K on October 15, 2025, to report the termination of a material definitive agreement. The filing does not provide specific details about the agreement or the parties involved, only that it has been terminated.
Why It Matters
The termination of a material definitive agreement can signal significant changes in a company's contractual relationships, potentially impacting its operations, financial standing, or future strategies.
Risk Assessment
Risk Level: medium — The termination of a material definitive agreement, without further details, introduces uncertainty about the company's business relationships and financial commitments.
Key Players & Entities
- Omega Healthcare Investors, Inc. (company) — Registrant
- October 15, 2025 (date) — Date of Report
FAQ
What was the nature of the material definitive agreement that was terminated?
The filing does not specify the nature of the material definitive agreement that was terminated.
Which parties were involved in the terminated agreement?
The filing does not disclose the names of the parties involved in the terminated agreement.
What is the effective date of the termination?
The filing indicates the termination was reported as of October 15, 2025, but does not specify the exact effective date of the termination itself.
Are there any financial implications resulting from this termination?
The filing does not provide information regarding the financial implications of the agreement's termination.
Will OHI be filing any amendments or further details regarding this termination?
The filing does not state whether further details or amendments will be provided.
Filing Stats: 600 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-10-15 16:16:11
Key Financial Figures
- $0.10 — ange on which registered Common Stock, $0.10 par value OHI New York Stock Exchan
- $600 million — ors, Inc. ("Omega") redeemed all of the $600 million aggregate principal amount of its outst
- $607,875,000 — r 15, 2025, Omega irrevocably deposited $607,875,000 with the Trustee for application to the
Filing Documents
- ohi-20251015x8k.htm (8-K) — 29KB
- 0000888491-25-000034.txt ( ) — 142KB
- ohi-20251015.xsd (EX-101.SCH) — 4KB
- ohi-20251015_def.xml (EX-101.DEF) — 3KB
- ohi-20251015_lab.xml (EX-101.LAB) — 13KB
- ohi-20251015_pre.xml (EX-101.PRE) — 10KB
- ohi-20251015x8k_htm.xml (XML) — 5KB
02 Termination of a Material Definitive Agreement
Item 1.02 Termination of a Material Definitive Agreement. On October 15, 2025, Omega Healthcare Investors, Inc. ("Omega") redeemed all of the $600 million aggregate principal amount of its outstanding 5.250% Senior Notes due 2026 (the "Notes"). The Notes were originally issued under an Indenture dated as of September 23, 2015, as amended and supplemented, or the Indenture, by and among Omega, certain of its subsidiaries, as guarantors, and U.S. Bank Trust Company, National Association, as Trustee. As previously reported, on September 15, 2025, at Omega's direction, the Trustee gave notice to the holders of the Notes of Omega's election to redeem all of the Notes on October 15, 2025. On October 15, 2025, Omega irrevocably deposited $607,875,000 with the Trustee for application to the payment of the redemption price of the Notes. The redemption price consisted of 100% of the principal amount of the Notes, plus accrued and unpaid interest on such notes to, but not including, the date of redemption. As a result of the foregoing, the obligations of Omega and its subsidiary guarantors under the Notes, the Indenture governing the Notes and the related subsidiary guarantees were terminated, and the Indenture was discharged. Notwithstanding the satisfaction and discharge of the Notes, the Indenture and the subsidiary guarantees, certain customary provisions of the Indenture relating to the compensation and indemnification of the Trustee and the application of trust money survive. U.S. Bank Trust Company, National Association has performed corporate trust services for Omega from time to time, for which it has received customary compensation, and may do so again in the future.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OMEGA HEALTHCARE INVESTORS, INC. Dated: October 15, 2025 By: /s/ Robert O. Stephenson Robert O. Stephenson Chief Financial Officer